Articles related to MOVEMENT DISORDERS

Take the time to explore this comprehensive review to understand more about essential tremor (ET), its underlying mechanisms, and the latest therapeutic approaches.

This case highlights the diagnostic intricacies of managing elderly patients with complex neurological symptoms, emphasizing the need for a comprehensive, multidisciplinary approach.

Discover the groundbreaking research that identifies a new type of brain cell with implications for memory, movement, and neurological disorders. Learn how this discovery could offer new therapeutic avenues for conditions like epilepsy and Parkinson’s disease.

The FDA’s approval of Daxxify offers a promising new treatment for cervical dystonia. Explore the comprehensive clinical data that supports this peptide-formulated neuromodulator’s efficacy and safety profile.

A deep examination of the Essential Tremor Centralized Brain Repository (ETCBR) uncovers fascinating associations between essential tremor (ET), Lewy pathology (LP), and other degenerative diseases, emphasizing the complexity of these interlinked neurological conditions.

This summary of a recent French study highlights that patients enabled to infuse apomorphine at home improved QoL more quickly and became more autonomous in managing the device compared with a hospital infusion group. The findings could be helpful to patients who would benefit from continuous subcutaneous apomorphine infusion (CSAI) but are deterred “by the wait for an appointment and the length of the subsequent hospital stay, as well as the physical distance from the nearest specialist center.”